These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12728674)

  • 1. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia].
    Kleszczewska E; Hejza J
    Pol Merkur Lekarski; 2003 Feb; 14(80):136-8. PubMed ID: 12728674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs].
    Galvez-Buccollini JA; Fiestas F; Herrera P; Vega-Dienstmaier JM; Guimas B; Mazzotti G
    Actas Esp Psiquiatr; 2004; 32(4):211-5. PubMed ID: 15232749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological treatments of schizophrenia].
    Dollfus S; Petit M
    Rev Prat; 1991 Mar; 41(7):615-9. PubMed ID: 1674170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia].
    Vanurová I; Yamamotová A
    Cas Lek Cesk; 2001 Oct; 140(21):668-70. PubMed ID: 11766456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late life schizophrenia and its treatment: pharmacologic issues in older schizophrenic patients.
    Tran-Johnson TK; Krull AJ; Jeste DV
    Clin Geriatr Med; 1992 May; 8(2):401-10. PubMed ID: 1350940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of schizophrenia drugs: a focus on dopaminergic systems.
    Nikam SS; Awasthi AK
    Curr Opin Investig Drugs; 2008 Jan; 9(1):37-46. PubMed ID: 18183530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy with neuroleptics and antidepressive agents: a fundamental and critical discussion from a biological viewpoint].
    Langer G
    Wien Klin Wochenschr; 1983 Jul; 95(14):474-8. PubMed ID: 6138904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2D6 genotype predicts antipsychotic side effects in schizophrenia inpatients: a retrospective matched case-control study.
    Kobylecki CJ; Jakobsen KD; Hansen T; Jakobsen IV; Rasmussen HB; Werge T
    Neuropsychobiology; 2009; 59(4):222-6. PubMed ID: 19521114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP 2D6 polymorphism and antipsychotic therapy.
    Plesnicar BK; Dolzan V; Zalar B
    Psychiatr Danub; 2008 Sep; 20(3):369-71. PubMed ID: 18827765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of neuroleptics based on their pharmacokinetics.
    Dahl SG
    Clin Neuropharmacol; 1986; 9 Suppl 4():409-11. PubMed ID: 2882845
    [No Abstract]   [Full Text] [Related]  

  • 12. What would the patient choose? Subjective comparison of atypical and typical neuroleptics.
    Karow A; Schnedler D; Naber D
    Pharmacopsychiatry; 2006 Mar; 39(2):47-51. PubMed ID: 16555164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia.
    Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H
    Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward convergence in the medication treatment of bipolar disorder and schizophrenia.
    Citrome L; Goldberg JF; Stahl SM
    Harv Rev Psychiatry; 2005; 13(1):28-42. PubMed ID: 15804932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic disinhibitory agents].
    Ginestet D
    Encephale; 1978; 4(5 Suppl):541-5. PubMed ID: 38105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum analysis of the EEG in schizophrenic patients.
    Vanderheeren F; Van Rompu E; Jannes C; Delaunois AL
    Arzneimittelforschung; 1979; 29(9):1437-9. PubMed ID: 42419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
    Kilian R; Angermeyer MC
    Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of a CYP2D6 poor metabolizer--a patient with schizophrenia on risperidone treatment.
    Bozina N; Jovanović N; Lovrić M; Medved V
    Ther Drug Monit; 2008 Dec; 30(6):748-51. PubMed ID: 18806696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.